| Dr Jonathan W Burress, DO | |
|
1 Medical Park Blvd, Suite 458w, Bristol, TN 37620-0000 | |
| (423) 230-6900 | |
| (423) 844-4987 |
| Full Name | Dr Jonathan W Burress |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 24 Years |
| Location | 1 Medical Park Blvd, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760415582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 1781 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Greeneville Community Hospital | Greeneville, TN | Hospital |
| Franklin Woods Community Hospital | Johnson city, TN | Hospital |
| Johnston Memorial Hospital | Abingdon, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellmont Cardiology Services | 5799970281 | 130 |
| Wellmont Medical Associates Inc | 8123291739 | 405 |
| Wellmont Cardiology Services | 5799970281 | 130 |
| Wellmont Medical Associates Inc | 8123291739 | 405 |
News Archive
According to research presented at the Nov 2011, American College of Rheumatology Annual Scientific Meeting in Chicago, a type of computed tomography scanning (commonly called CT scans) appears to help in the diagnosis of gout by detecting the urate crystals that are often a symptom of the disease.
States struggle with funding health care for inmates, Medicaid cuts and funding health insurance for low-income residents in Minnestoa.
Bristol-Myers Squibb Company today announced positive results from a Phase 3 randomized, double blind study of ipilimumab which demonstrated that overall survival was significantly extended in patients with previously-treated metastatic melanoma who received ipilimumab.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Judith Jennrich, PhD, RN, ACNP, associate professor, Loyola University Chicago Marcella Niehoff School of Nursing (MNSON), has been selected as a 2012 Power of Nursing Leadership SAGE award winner. The SAGE award honors nurses who mentor and support leaders of today while looking for ways to guide nurse leaders of tomorrow. Dr. Jennrich will be recognized at the 15th Annual Power of Nursing Leadership celebration on Friday, Nov. 2, in Chicago.
› Verified 1 days ago
| Entity Name | Wellmont Cardiology Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376575035 PECOS PAC ID: 5799970281 Enrollment ID: O20101215000083 |
News Archive
According to research presented at the Nov 2011, American College of Rheumatology Annual Scientific Meeting in Chicago, a type of computed tomography scanning (commonly called CT scans) appears to help in the diagnosis of gout by detecting the urate crystals that are often a symptom of the disease.
States struggle with funding health care for inmates, Medicaid cuts and funding health insurance for low-income residents in Minnestoa.
Bristol-Myers Squibb Company today announced positive results from a Phase 3 randomized, double blind study of ipilimumab which demonstrated that overall survival was significantly extended in patients with previously-treated metastatic melanoma who received ipilimumab.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Judith Jennrich, PhD, RN, ACNP, associate professor, Loyola University Chicago Marcella Niehoff School of Nursing (MNSON), has been selected as a 2012 Power of Nursing Leadership SAGE award winner. The SAGE award honors nurses who mentor and support leaders of today while looking for ways to guide nurse leaders of tomorrow. Dr. Jennrich will be recognized at the 15th Annual Power of Nursing Leadership celebration on Friday, Nov. 2, in Chicago.
› Verified 1 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780986257 PECOS PAC ID: 8123291739 Enrollment ID: O20111026000909 |
News Archive
According to research presented at the Nov 2011, American College of Rheumatology Annual Scientific Meeting in Chicago, a type of computed tomography scanning (commonly called CT scans) appears to help in the diagnosis of gout by detecting the urate crystals that are often a symptom of the disease.
States struggle with funding health care for inmates, Medicaid cuts and funding health insurance for low-income residents in Minnestoa.
Bristol-Myers Squibb Company today announced positive results from a Phase 3 randomized, double blind study of ipilimumab which demonstrated that overall survival was significantly extended in patients with previously-treated metastatic melanoma who received ipilimumab.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Judith Jennrich, PhD, RN, ACNP, associate professor, Loyola University Chicago Marcella Niehoff School of Nursing (MNSON), has been selected as a 2012 Power of Nursing Leadership SAGE award winner. The SAGE award honors nurses who mentor and support leaders of today while looking for ways to guide nurse leaders of tomorrow. Dr. Jennrich will be recognized at the 15th Annual Power of Nursing Leadership celebration on Friday, Nov. 2, in Chicago.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan W Burress, DO 105 W Stone Dr, Suite 6a, Kingsport, TN 37660-3365 Ph: (423) 408-7220 | Dr Jonathan W Burress, DO 1 Medical Park Blvd, Suite 458w, Bristol, TN 37620-0000 Ph: (423) 230-6900 |
News Archive
According to research presented at the Nov 2011, American College of Rheumatology Annual Scientific Meeting in Chicago, a type of computed tomography scanning (commonly called CT scans) appears to help in the diagnosis of gout by detecting the urate crystals that are often a symptom of the disease.
States struggle with funding health care for inmates, Medicaid cuts and funding health insurance for low-income residents in Minnestoa.
Bristol-Myers Squibb Company today announced positive results from a Phase 3 randomized, double blind study of ipilimumab which demonstrated that overall survival was significantly extended in patients with previously-treated metastatic melanoma who received ipilimumab.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Judith Jennrich, PhD, RN, ACNP, associate professor, Loyola University Chicago Marcella Niehoff School of Nursing (MNSON), has been selected as a 2012 Power of Nursing Leadership SAGE award winner. The SAGE award honors nurses who mentor and support leaders of today while looking for ways to guide nurse leaders of tomorrow. Dr. Jennrich will be recognized at the 15th Annual Power of Nursing Leadership celebration on Friday, Nov. 2, in Chicago.
› Verified 1 days ago
Dr. Nafees Ameer Mohammed, MBBS Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 271 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-4800 Fax: 423-230-6905 | |
Rick Whiles, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Park Blvd, Ste 3600, Bristol, TN 37620 Phone: 423-990-2414 | |
Dr. Jean Marie Mancini, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Ste 450w, Bristol, TN 37620 Phone: 423-968-3713 Fax: 423-986-7352 | |
Dr. Craig S Graul, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 104 Manchester Pl, Bristol, TN 37620 Phone: 423-573-1988 | |
Roger J Mcsharry, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 271 Medical Park Blvd, Bristol, TN 37620 Phone: 423-968-2311 Fax: 423-968-2311 | |
Steven Michael Tomski, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Park Blvd Ste 2000, Bristol, TN 37620 Phone: 423-990-5495 Fax: 423-990-2492 | |
Theodore Thompson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1220 Volunteer Pkwy, Bristol, TN 37620 Phone: 423-274-6610 Fax: 423-274-6619 |